These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12578850)

  • 21. Down-regulation of stromal cell-derived factor-1alpha-induced T cell chemotaxis by a peptide based on the complementarity-determining region 1 of an anti-DNA autoantibody via up-regulation of TGF-beta secretion.
    Sela U; Hershkoviz R; Cahalon L; Lider O; Mozes E
    J Immunol; 2005 Jan; 174(1):302-9. PubMed ID: 15611253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gr-1(high) CD11b+ cells suppress B cell differentiation and lupus-like disease in lupus-prone male mice.
    Trigunaite A; Khan A; Der E; Song A; Varikuti S; Jørgensen TN
    Arthritis Rheum; 2013 Sep; 65(9):2392-402. PubMed ID: 23754362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-beta.
    Sharabi A; Zinger H; Zborowsky M; Sthoeger ZM; Mozes E
    Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8810-5. PubMed ID: 16735466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amelioration of brain pathology and behavioral dysfunction in mice with lupus following treatment with a tolerogenic peptide.
    Lapter S; Marom A; Meshorer A; Elmann A; Sharabi A; Vadai E; Neufeld A; Sztainberg Y; Gil S; Getselter D; Chen A; Mozes E
    Arthritis Rheum; 2009 Dec; 60(12):3744-54. PubMed ID: 19950283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.
    Karpouzas GA; La Cava A; Ebling FM; Singh RR; Hahn BH
    Eur J Immunol; 2004 Sep; 34(9):2489-99. PubMed ID: 15307181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus.
    Decker DA; Grant C; Oh L; Becker PM; Young D; Jordan S
    Lupus; 2014 Jul; 23(8):802-12. PubMed ID: 24759631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of autoantibody production by mycophenolate mofetil: effects on the development of SLE in (NZB x NZW)F1 mice.
    Ramos MA; Piñera C; Setién MA; Buelta L; de Cos MA; de Francisco AL; Merino R; Arias M
    Nephrol Dial Transplant; 2003 May; 18(5):878-83. PubMed ID: 12686658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P; Langnickel D; Riemekasten G
    Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice.
    Gioud M; Kotzin BL; Rubin RL; Joslin FG; Tan EM
    J Immunol; 1983 Jul; 131(1):269-74. PubMed ID: 6863918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization with peptides derived from the idiotypic region of lupus-associated autoantibodies delays the development of lupus nephritis in the (SWR x NZB)F1 murine model.
    Stoll ML; Price KD; Silvin CJ; Jiang F; Gavalchin J
    J Autoimmun; 2007 Aug; 29(1):30-7. PubMed ID: 17459659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early hyperbaric oxygen therapy attenuates disease severity in lupus-prone autoimmune (NZB x NZW) F1 mice.
    Chen SY; Chen YC; Wang JK; Hsu HP; Ho PS; Chen YC; Sytwu HK
    Clin Immunol; 2003 Aug; 108(2):103-10. PubMed ID: 12921756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inhibition of autoreactive T cell functions by a peptide based on the CDR1 of an anti-DNA autoantibody is via TGF-beta-mediated suppression of LFA-1 and CD44 expression and function.
    Sela U; Mauermann N; Hershkoviz R; Zinger H; Dayan M; Cahalon L; Liu JP; Mozes E; Lider O
    J Immunol; 2005 Dec; 175(11):7255-63. PubMed ID: 16301630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ongoing immunologic activity after short courses of pulse cyclophosphamide in the NZB/W murine model of systemic lupus erythematosus.
    Austin HA; Patel AD; Cadena CA; Boumpas DT; Balow JE
    J Rheumatol; 1997 Jan; 24(1):61-8. PubMed ID: 9002012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
    Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
    Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus.
    Jiang Y; Hirose S; Sanokawa-Akakura R; Abe M; Mi X; Li N; Miura Y; Shirai J; Zhang D; Hamano Y; Shirai T
    Int Immunol; 1999 Oct; 11(10):1685-91. PubMed ID: 10508186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28.
    Laurent L; Le Fur A; Bloas RL; Néel M; Mary C; Moreau A; Poirier N; Vanhove B; Fakhouri F
    Eur J Immunol; 2017 Aug; 47(8):1368-1376. PubMed ID: 28631301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
    Starke C; Steinkasserer A; Voll RE; Zinser E
    Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissection of the effects of tumor necrosis factor-alpha and class II gene polymorphisms within the MHC on murine systemic lupus erythematosus (SLE).
    Fujimura T; Hirose S; Jiang Y; Kodera S; Ohmuro H; Zhang D; Hamano Y; Ishida H; Furukawa S; Shirai T
    Int Immunol; 1998 Oct; 10(10):1467-72. PubMed ID: 9796913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.
    Zhang M; Yu G; Chan B; Pearson JT; Rathanaswami P; Delaney J; Ching Lim A; Babcook J; Hsu H; Gavin MA
    Arthritis Rheumatol; 2015 Oct; 67(10):2723-31. PubMed ID: 26097207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.